Published in J Peripher Nerv Syst on March 01, 2009
Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes (BARI2D) | NCT00006305
Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. Diabetes Care (2011) 1.88
Mechanism of diabetic neuropathy: Where are we now and where to go? J Diabetes Investig (2011) 1.25
Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes. Diabetes (2014) 1.01
AMPK: An emerging target for modification of injury-induced pain plasticity. Neurosci Lett (2013) 0.91
Peripheral and Autonomic Neuropathy in South Asians and White Caucasians with Type 2 Diabetes Mellitus: Possible Explanations for Epidemiological Differences. J Diabetes Res (2017) 0.88
Progressive axonal dysfunction precedes development of neuropathy in type 2 diabetes. Diabetes (2012) 0.87
The use of metformin is associated with decreased lumbar radiculopathy pain. J Pain Res (2013) 0.83
Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort. Diabetes Care (2013) 0.82
The influence of autonomic dysfunction associated with aging and type 2 diabetes on daily life activities. Exp Diabetes Res (2012) 0.81
Diabetic Polyneuropathy in Type 2 Diabetes Mellitus: Inflammation, Oxidative Stress, and Mitochondrial Function. J Diabetes Res (2016) 0.80
Potential of Dietary Non-Provitamin A Carotenoids in the Prevention and Treatment of Diabetic Microvascular Complications. Adv Nutr (2016) 0.76
Adenosine Monophosphate-activated Protein Kinase (AMPK) Activators For the Prevention, Treatment and Potential Reversal of Pathological Pain. Curr Drug Targets (2016) 0.76
Physical Exercise Improves Heart Rate Variability in Patients with Type 2 Diabetes: A Systematic Review. Curr Diab Rep (2017) 0.75
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (1998) 34.34
Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract (1995) 12.51
Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care (2005) 7.81
A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care (1994) 5.02
The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). Diabetologia (1998) 3.05
Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. Diabetes Care (2006) 2.64
Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial. Ann Neurol (1995) 2.47
Baseline characteristics of patients with diabetes and coronary artery disease enrolled in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Am Heart J (2008) 2.40
Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort. Neurology (1997) 2.23
Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients. Diabetes Care (1990) 1.90
Metformin prevents high-glucose-induced endothelial cell death through a mitochondrial permeability transition-dependent process. Diabetes (2005) 1.85
Risk factors for distal symmetric neuropathy in NIDDM. The San Luis Valley Diabetes Study. Diabetes Care (1994) 1.74
Diabetic peripheral neuropathy and depressive symptoms: the association revisited. Diabetes Care (2005) 1.65
Diabetic neuropathy and oxidative stress. Diabetes Metab Res Rev (2006) 1.58
Neuroprotective role of antidiabetic drug metformin against apoptotic cell death in primary cortical neurons. J Mol Neurosci (2007) 1.50
[Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 (3rd and last part) (author's transl)]. Diabete Metab (1977) 1.48
Endothelial inflammation in insulin resistance. Lancet (2005) 1.46
Angiotensin II regulation of collagen type I expression in cardiac fibroblasts: modulation by PPAR-gamma ligand pioglitazone. Hypertension (2004) 1.38
The effects of intensive glycemic control on neuropathy in the VA cooperative study on type II diabetes mellitus (VA CSDM). J Diabetes Complications (2000) 1.33
C-peptide corrects endoneurial blood flow but not oxidative stress in type 1 BB/Wor rats. Am J Physiol Endocrinol Metab (2004) 1.10
Correction of protein kinase C activity and macrophage migration in peripheral nerve by pioglitazone, peroxisome proliferator activated-gamma-ligand, in insulin-deficient diabetic rats. J Neurochem (2007) 1.04
Activation of cerebral peroxisome proliferator-activated receptors gamma exerts neuroprotection by inhibiting oxidative stress following pilocarpine-induced status epilepticus. Brain Res (2008) 1.03
Neuroprotection with pioglitazone against LPS insult on dopaminergic neurons may be associated with its inhibition of NF-kappaB and JNK activation and suppression of COX-2 activity. J Neuroimmunol (2007) 0.98
Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study. Proc Assoc Am Physicians (1997) 0.93
Natural progression of diabetic peripheral neuropathy in the Zenarestat study population. Diabetes Care (2004) 0.90
Mitochondrial ATP-sensitive potassium channel: a novel site for neuroprotection. Invest Ophthalmol Vis Sci (2003) 0.89
Neuroprotective effect of the new thiadiazolidinone NP00111 against oxygen-glucose deprivation in rat hippocampal slices: implication of ERK1/2 and PPARgamma receptors. Exp Neurol (2008) 0.85
Risk factors for lower limb complications in diabetic patients. The Italian Study Group for the Implementation of the St. Vincent Declaration. J Diabetes Complications (1998) 0.82
Potentiating effect of the ATP-sensitive potassium channel blocker glibenclamide on complex I inhibitor neurotoxicity in vitro and in vivo. Neurotoxicology (2006) 0.81
A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med (2009) 12.15
Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation (2010) 2.64
Rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Circulation (2013) 2.15
Meiotic arrest in the mouse follicle maintained by a Gs protein in the oocyte. Science (2002) 1.86
Profibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Circulation (2011) 1.81
Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease. Circulation (2011) 1.75
Prognostic impact of the presence and absence of angina on mortality and cardiovascular outcomes in patients with type 2 diabetes and stable coronary artery disease: results from the BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) trial. J Am Coll Cardiol (2013) 1.55
Relation of severe coronary artery narrowing to insulin or thiazolidinedione use in patients with type 2 diabetes mellitus (from the Bypass Angioplasty Revascularization Investigation 2 Diabetes Study). Am J Cardiol (2009) 1.42
Whole genome wide expression profiles of Vitis amurensis grape responding to downy mildew by using Solexa sequencing technology. BMC Plant Biol (2010) 1.36
Retinal vascular caliber as a biomarker for diabetes microvascular complications. Diabetes Care (2013) 1.32
Regulation of meiotic prophase arrest in mouse oocytes by GPR3, a constitutive activator of the Gs G protein. J Cell Biol (2005) 1.24
What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes. J Cardiovasc Transl Res (2012) 1.17
Hsp90 interactions and acylation target the G protein Galpha 12 but not Galpha 13 to lipid rafts. J Biol Chem (2002) 1.13
TCF7L2 polymorphism rs7903146 is associated with coronary artery disease severity and mortality. PLoS One (2009) 1.11
A sample size adjustment procedure for clinical trials based on conditional power. Biostatistics (2002) 1.09
Maintenance of meiotic prophase arrest in vertebrate oocytes by a Gs protein-mediated pathway. Dev Biol (2004) 1.07
Impact of diabetes on five-year outcomes of patients with multivessel coronary artery disease. Ann Thorac Surg (2007) 1.02
Activated monocytes induce smooth muscle cell death: role of macrophage colony-stimulating factor and cell contact. Circulation (2002) 0.98
Baseline coronary angiographic findings in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial (BARI 2D). Am J Cardiol (2009) 0.97
Phenolic contents and compositions in skins of red wine grape cultivars among various genetic backgrounds and originations. Int J Mol Sci (2012) 0.95
Over-expression of neuroepithelial-transforming protein 1 confers poor prognosis of patients with gliomas. Jpn J Clin Oncol (2010) 0.91
Synergistic effects of electrospun PLLA fiber dimension and pattern on neonatal mouse cerebellum C17.2 stem cells. Acta Biomater (2010) 0.90
Manufacture of PLGA multiple-channel conduits with precise hierarchical pore architectures and in vitro/vivo evaluation for spinal cord injury. Tissue Eng Part C Methods (2009) 0.90
A comparison of principal component analysis and factor analysis strategies for uncovering pleiotropic factors. Genet Epidemiol (2009) 0.88
RGS16 inhibits signalling through the G alpha 13-Rho axis. Nat Cell Biol (2003) 0.87
Microstructure and properties of nano-fibrous PCL-b-PLLA scaffolds for cartilage tissue engineering. Eur Cell Mater (2009) 0.86
Mining and validating grape (Vitis L.) ESTs to develop EST-SSR markers for genotyping and mapping. Mol Breed (2010) 0.85
Quality of life in patients with symptomatic multivessel coronary artery disease: a comparative post hoc analyses of medical, angioplasty or surgical strategies-MASS II trial. Int J Cardiol (2006) 0.85
Influence of growing season on phenolic compounds and antioxidant properties of grape berries from vines grown in subtropical climate. J Agric Food Chem (2011) 0.84
Effect of a hypoglycemic agent on ischemic preconditioning in patients with type 2 diabetes and stable angina pectoris. Coron Artery Dis (2007) 0.84
Resting heart rate and metabolic syndrome in patients with diabetes and coronary artery disease in bypass angioplasty revascularization investigation 2 diabetes (BARI 2D) trial. Prev Cardiol (2010) 0.84
Five-year follow-up of angiographic disease progression after medicine, angioplasty, or surgery. J Cardiothorac Surg (2010) 0.83
Presentation in patients with angiographically documented coronary artery disease and type II diabetes mellitus (from the BARI 2D Clinical Trial). Am J Cardiol (2011) 0.83
Quality of life after surgical myocardial revascularization, angioplasty or medical treatment. Arq Bras Cardiol (2007) 0.83
The effect of internal thoracic artery grafts on long-term clinical outcomes after coronary bypass surgery. J Thorac Cardiovasc Surg (2011) 0.83
The mode of host resistance to Plasmopara viticola infection of grapevines. Phytopathology (2012) 0.82
Relationships of obesity and fat distribution with atherothrombotic risk factors: baseline results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Obesity (Silver Spring) (2009) 0.82
Antioxidant, antibacterial, and antibiofilm properties of polyphenols from muscadine grape (Vitis rotundifolia Michx.) pomace against selected foodborne pathogens. J Agric Food Chem (2014) 0.82
Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort. Diabetes Care (2013) 0.82
Characterization and partial purification of protein fatty acyltransferase activity from rat liver. Biochim Biophys Acta (2003) 0.82
Effects of (12)C(6+) ion radiation and ferulic acid on the zebrafish (Danio rerio) embryonic oxidative stress response and gene expression. Mutat Res (2013) 0.81
Phenolic concentrations and antioxidant properties of wines made from north american grapes grown in china. Molecules (2012) 0.81
Muscadine grape seed oil as a novel source of tocotrienols to reduce adipogenesis and adipocyte inflammation. Food Funct (2015) 0.80
[The prevalence of mild cognitive impairment among residents aged 55 or over in Chengdu area]. Zhonghua Liu Xing Bing Xue Za Zhi (2003) 0.80
Association between increased platelet P-selectin expression and obesity in patients with type 2 diabetes: a BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) substudy. Diabetes Care (2009) 0.80
The influence of laminin-derived peptides conjugated to Lys-capped PLLA on neonatal mouse cerebellum C17.2 stem cells. Biomaterials (2009) 0.79
Resistance to Elsinoë ampelina and expression of related resistant genes in Vitis rotundifolia Michx. grapes. Int J Mol Sci (2011) 0.79
Sex, clinical symptoms, and angiographic findings in patients with diabetes mellitus and coronary artery disease (from the Bypass Angioplasty Revascularization Investigation [BARI] 2 Diabetes trial). Am J Cardiol (2011) 0.79
[Prognostic analysis of stage III-IV non-small cell lung cancer patients treated by traditional chinese medicine]. Ai Zheng (2005) 0.78
Preparation and electrophilic cyclization of multisubstituted dienamides leading to cyclic iminoethers. J Org Chem (2005) 0.78
Response to letter regarding article, "rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial". Circulation (2014) 0.77
Chagas disease as a mechanistic model for testing a novel hypothesis. Rev Soc Bras Med Trop (2008) 0.77
Associations between three polymorphisms in the interleukin-4 receptor gene and risk of cancer: a meta-analysis. Asian Pac J Cancer Prev (2012) 0.77
International collaborative research on Charcot's disease. Lancet (2009) 0.77
Partial rescue of functional interactions of a nonpalmitoylated mutant of the G-protein G alpha s by fusion to the beta-adrenergic receptor. Biochemistry (2003) 0.77
Geographic distribution of cryptic species of Plasmopara viticola causing downy mildew on wild and cultivated grape in eastern North America. Phytopathology (2014) 0.77
Effects of gastric electric stimulation on gastric distention responsive neurons and expressions of CCK in rodent hippocampus. Obesity (Silver Spring) (2008) 0.76
Isolation of a WRKY30 gene from Muscadinia rotundifolia (Michx) and validation of its function under biotic and abiotic stresses. Protoplasma (2015) 0.76
Linkage of cold acclimation and disease resistance through plant-pathogen interaction pathway in Vitis amurensis grapevine. Funct Integr Genomics (2014) 0.76
Change in enrollment patterns, patient selection, and clinical outcomes with the availability of drug-eluting stents in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial. Am Heart J (2013) 0.75
Hypotheses, rationale, design, and methods for prognostic evaluation in type 2 diabetic patients with angiographically normal coronary arteries. The MASS IV-DM Trial. BMC Cardiovasc Disord (2010) 0.75
Culprit lesion revascularisation initially costs less and is more successful than complete revascularisation in multivessel disease, but results equalise over time. Commentary. Evid Based Cardiovasc Med (2005) 0.75
[Patient with pemphigus vulgaris complicated with dysfunctional uterine bleeding upon glucocorticoid usage: a case report]. Hua Xi Kou Qiang Yi Xue Za Zhi (2015) 0.75
Life cycle assessment in the environmental impact evaluation of urban development--a case study of land readjustment project, Hyogo District, Japan. J Zhejiang Univ Sci (2003) 0.75
Therapeutic effect of RANTES-KDEL on inhibition of HIV-1 in CD34(+) human hematopoietic stem cells (hHSC). J Virol Methods (2008) 0.75
Gaussia luciferase reporter assay for assessment of gene delivery systems in vivo. Chin Med Sci J (2010) 0.75
Physical and chemical stability of gum arabic-stabilized conjugated linoleic acid oil-in-water emulsions. J Agric Food Chem (2013) 0.75
Effect of motilin on the discharge of rat hippocampal neurons responding to gastric distension and its potential mechanism. Peptides (2007) 0.75